LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy
Open Access
- 31 August 2000
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 151 (2) , 551-557
- https://doi.org/10.1016/s0021-9150(99)00426-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-IAtherosclerosis, 1997
- Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like growth factor IExperimental and Clinical Endocrinology & Diabetes, 1997
- Short-Term Effects of Octreotide on Glucose Tolerance in Patients with Acromegaly.Endocrine Journal, 1995
- Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDMEuropean Journal of Clinical Investigation, 1994
- Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegalyAtherosclerosis, 1993
- Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Effects of Octreotide on Lipid Metabolism in AcromegalyHormone and Metabolic Research, 1992
- Impact of octreotide, a long‐acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegalyClinical Endocrinology, 1992
- Carbohydrate Tolerance and Serum Lipids in Acromegaly Before and During Treatment with High Dose OctreotideDiabetic Medicine, 1991